Selected INSTI Highlights - CROI 2019 - Charles Boucher, MD, PhD

Asia-Pacific HIV Clinical Forum 2019

The Impact of Antiretroviral Drug Resistance in Taiwanese HIV-1-Infected MSM Population Between 2015 and 2018 - Yen-Ju Chen

Asia-Pacific HIV Clinical Forum 2019

Trends of Genotypic Sensitivity Scores of HIV-1 in Taiwan: Potential Application in the Selection of Single-Tablet Antiretroviral Regimens - Kuan-Yeh Lee

Asia-Pacific HIV Clinical Forum 2019

Clinical experience INSTI in Japan S- Shinichi Oka, MD, PhD

Asia-Pacific HIV Clinical Forum 2019

Clinical experience INSTI in Thailand - Kiat Ruxrungtham, MD

Asia-Pacific HIV Clinical Forum 2019

Transmitted drug resistance to integrase inhibitors is uncommon in both acute and chronic HIV infection in Bangkok - Donn Colby

Asia-Pacific HIV Clinical Forum 2019

Starting PrEP During Acute HIV Infection: What is the Risk for Antiretroviral Drug Resistance? - Donn Colby

Asia-Pacific HIV Clinical Forum 2019

Dolutegravir Plus Tenofovir Disoproxil Fumarate/ Emtricitabine as HIV Post-Exposure Prophylaxis: Efficacy and Safety Results from Real World Study - Chongxi Li

Asia-Pacific HIV Clinical Forum 2019

INSTI Use in Women of Child-Bearing Age - NTD Toxicity - Natella Rakhmanina, MD, PhD, FAAP, FCP, AAHIVS

Asia-Pacific HIV Clinical Forum 2019

Reduced Drug Regimens - Pedro Cahn, MD, PhD

Asia-Pacific HIV Clinical Forum 2019

Challenges in Caring for HIV-TB Coinfected Patients - Grace Chung-Yan Lui, MBChB (Hons), FHKCP, FHKAM

Asia-Pacific HIV Clinical Forum 2019

Update on Long Acting Antiretroviral Drugs - Saye Khoo, MD, PhD

Asia-Pacific HIV Clinical Forum 2019

INSTI Research in Asia - What are the Remaining Gaps? - Mark Boyd, BA, BM, BS, DCTH&H, MHID, MD, FRACP

Asia-Pacific HIV Clinical Forum 2019